Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines
Monell Chemical Senses Center · with NIAID, Division of AIDS (contract funder), Advanced Biosciences Laboratories (ABL; primary contract holder) · NCT06929455
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–60 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 100
- US sites recruiting
- 1
- Study start
- March 18, 2025
- Record last updated
- April 16, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Many people, particularly small children, must take drugs in liquid form because they cannot swallow pills or capsules. The bad taste of some liquid drugs can keep patients from taking drugs they need for their health. Our main goal in this research study is find ingredients that might make drugs taste better.
Participants in this research study will be healthy adults between the ages of 18 and 60 years old. Participants will taste samples (liquids or gels) containing active pharmaceutical ingredients (substances in medications that produce desired health effects). After tasting each sample participants will spit out the sample and rinse with water (no samples will be swallowed). Active pharmaceutical ingredients of current interest are: 1) tenofovir alafenamide, used to treat HIV infection and hepatitis B, 2) rifampicin, used to treat tuberculosis, 3) rifapentine, used to treat tuberculosis, and 4) levofloxacin, used to treat various bacterial infections). Other active pharmaceutical ingredients may be added as the study goes forward. Participants will be instructed to taste samples both with and without experimental flavor ingredients added and judge how the samples taste. People who volunteer for the study will be instructed to complete many repeated visits to the Monell Center (University City area of Philadelphia) for tasting sessions. Tasting visits will last between 1 and 2 hours.
Being studied: Flavor additives
Conditions: Healthy Adults
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Between the ages of 18 and 60;
- Generally healthy by self-report;
- All races/ethnicities, both men and women;
- Able to provide informed consent;
- Able to attend repeated visits to Monell for sensory testing;
- Willing to follow instructions (e.g., refrain from eating or drinking for at least 1 hour before sessions, willing to remain on site for one hour after tasting an API that the participant has never tasted before). -
Exclusion Criteria
- Under 18 or over 60;
- Pregnant, nursing, or plans to become pregnant;
- Unable to provide consent (including limited ability to understand written and spoken English);
- Tobacco, vape, marijuana, or tetrahydrocannabinol cartridge users. We will accept people who have used tobacco or marijuana products on occasion, but not regular users;
- Known drug or food allergies of any kind;
- Diabetes or other metabolic disorder;
- Liver issues of any kind, including viral hepatitis;
- Kidney issues of any kind;
- Other chronic illness, including cardiovascular, neurological, immune disorders, or any other serious acute or chronic condition
- Dentures or other major dental implants;
- Condition affecting the oral cavity, including dry mouth, burning mouth syndrome, active sores or blisters, geographic tongue, or other disorders
- Current infection or cold, flu, or infection with SARS-CoV-2 within the last four weeks;
- Unable to taste or smell
- Daily use, or use within the last four weeks, of either prescription or over-the-counter medications (except for birth control)
- History of tuberculosis (including latent tuberculosis), positive skin or other tuberculosis test at any time in the past, birth in or residence in a country with high tuberculosis rates, known contact with someone who is tuberculosis positive
- HIV infection
Recruiting US locations
Monell Chemical Senses Center
Philadelphia, PA 19104
Site contact: Paul M Wise, Ph.D. · 267-519-0400 · pwise@monell.org
Study contacts (from the official record)
- Paul M Wise, Ph.D. · 267-519-4799 · TasteOfMedicinesStudy@monell.org
Similar studies in Pennsylvania
All healthy volunteers studies in Pennsylvania →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
Melissa Pugliano-Mauro
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Philadelphia, PA + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Philadelphia, PA + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Novo Nordisk A/S
- Location
- Hershey, PA + 4 other US sites
- Eligibility basics
- Ages 18–64 · Men only